Maria G. Carnevale

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)].

Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)].

Journal: EClinicalMedicine

Published: February 09, 2026

Ultra-hypofractionated whole breast irradiation in early-stage breast cancer: an Italian multi-centre observational study.

Ultra-hypofractionated whole breast irradiation in early-stage breast cancer: an Italian multi-centre observational study.

Journal: International journal of radiation oncology, biology, physics

Published: January 17, 2026

Event-Free Survival After Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Breast Cancer.

Event-Free Survival After Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Breast Cancer.

Journal: Clinical breast cancer

Published: September 28, 2025

HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy.

HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy.

Journal: NPJ breast cancer

Published: August 07, 2025

Health-related quality of life and fear of recurrence after early breast cancer treatment: Results from a cross-sectional survey.

Health-related quality of life and fear of recurrence after early breast cancer treatment: Results from a cross-sectional survey.

Journal: Breast (Edinburgh, Scotland)

Published: August 05, 2025

Real world feasibility of combining pembrolizumab with radiotherapy in early triple negative breast cancer.

Real world feasibility of combining pembrolizumab with radiotherapy in early triple negative breast cancer.

Journal: Discover oncology

Published: February 02, 2025

Advancing breast cancer therapy in the era of molecular diagnostics.

Advancing breast cancer therapy in the era of molecular diagnostics.

Journal: Breast (Edinburgh, Scotland)

Published: December 04, 2024

Reliability of core needle biopsy for HER2-low early-stage breast cancer.

Reliability of core needle biopsy for HER2-low early-stage breast cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 03, 2024

Fat necrosis after accelerated partial breast irradiation or hypofractionated whole breast irradiation: A case-control study.

Fat necrosis after accelerated partial breast irradiation or hypofractionated whole breast irradiation: A case-control study.

Journal: Tumori

Published: October 25, 2024

Treatment of oligometastatic breast cancer: The role of patient selection.

Treatment of oligometastatic breast cancer: The role of patient selection.

Journal: Breast (Edinburgh, Scotland)

Published: July 22, 2024

Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancer.

Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancer.

Journal: Scientific reports

Published: May 24, 2024

Spent coffee ground characterization, pelletization test and emissions assessment in the combustion process.

Spent coffee ground characterization, pelletization test and emissions assessment in the combustion process.

Journal: Scientific reports

Published: September 17, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026